Identifying research priorities in breast cancer surgery: a UK priority setting partnership with the James Lind Alliance
- PMID: 36319906
- PMCID: PMC9628302
- DOI: 10.1007/s10549-022-06756-4
Identifying research priorities in breast cancer surgery: a UK priority setting partnership with the James Lind Alliance
Abstract
Purpose: A James Lind Alliance priority setting partnership was developed to identify research priorities in breast cancer surgery from individuals with lived experience, at high genetic risk of breast cancer, and healthcare professionals (HCPs).
Methods: 'Uncertainties' were collected using an online survey. Following an evidence check and development of summary questions, an interim survey asked participants to rank their top 10 research priorities from the question list. Top-ranked questions from patient/carer, high-risk and professional groups were carried forward for discussion to a final online prioritisation workshop.
Results: 260 participants (101 patients/carers, 156 HCPs) submitted 940 uncertainties via the initial survey. These were analysed thematically into 128 summary questions in six topic areas. Following evidence checking, 59 questions were included in the interim survey which was completed by 572 respondents. Marked differences were seen in questions prioritised by patients/carers, HCPs and women at high-risk. The top eight priorities in patient/carer and professional groups and top two priorities for high-risk women were carried forward to the online workshop at which 22 participants discussed and agreed the final top 10. Key themes included de-escalation of breast and axillary surgery, factors impacting the development/detection of locoregional recurrence and optimal provision of support for informed treatment decision-making.
Conclusion: The top 10 research priorities in breast cancer surgery have been agreed. However, the observed differences in research priorities identified by patients and professional groups were not anticipated. Top priorities from both groups should inform future UK breast cancer surgical research, to ensure that it addresses questions that are important to breast cancer community as a whole.
Keywords: Breast cancer surgery; Consensus; James Lind Alliance; Research priorities.
© 2022. The Author(s).
Conflict of interest statement
RIC reports institutional research funding from SECA and Astra Zeneca. SMcI reports institutional research funding from Novartis and Sanofi, advisory boards for Roche and Lilly, honoraria from Roche, BD and Daiichi-Sankyo, and conference travel and support from Roche and Lilly. The remaining authors declare they have no relevant financial or non-financial interests.
Figures
Similar articles
-
Identifying research priorities for improving information and support for patients undergoing breast cancer surgery: a UK patient-centred priority setting project.Breast Cancer Res Treat. 2024 Nov;208(1):215-222. doi: 10.1007/s10549-024-07413-8. Epub 2024 Jun 24. Breast Cancer Res Treat. 2024. PMID: 38914917 Free PMC article.
-
Research priorities for pregnancy hypertension: a UK priority setting partnership with the James Lind Alliance.BMJ Open. 2020 Jul 14;10(7):e036347. doi: 10.1136/bmjopen-2019-036347. BMJ Open. 2020. PMID: 32665388 Free PMC article.
-
Identifying and prioritising unanswered research questions for people with hyperacusis: James Lind Alliance Hyperacusis Priority Setting Partnership.BMJ Open. 2019 Nov 21;9(11):e032178. doi: 10.1136/bmjopen-2019-032178. BMJ Open. 2019. PMID: 31753886 Free PMC article.
-
What are the most important unanswered research questions in trial retention? A James Lind Alliance Priority Setting Partnership: the PRioRiTy II (Prioritising Retention in Randomised Trials) study.Trials. 2019 Oct 15;20(1):593. doi: 10.1186/s13063-019-3687-7. Trials. 2019. PMID: 31615577 Free PMC article.
-
Top 10 research priorities for digital technology for adolescents and young persons with inflammatory bowel disease: Results of a James Lind Alliance Priority Setting Partnership.J Pediatr Gastroenterol Nutr. 2024 Mar;78(3):670-676. doi: 10.1002/jpn3.12105. Epub 2024 Jan 4. J Pediatr Gastroenterol Nutr. 2024. PMID: 38504402 Review.
Cited by
-
Long-term patient-reported outcomes of immediate breast reconstruction after mastectomy for breast cancer: population-based cohort study.Br J Surg. 2023 Nov 9;110(12):1815-1823. doi: 10.1093/bjs/znad276. Br J Surg. 2023. PMID: 37766501 Free PMC article.
-
Current use of drains and management of seroma following mastectomy and axillary surgery: results of a United Kingdom national practice survey.Breast Cancer Res Treat. 2024 Jan;203(2):187-196. doi: 10.1007/s10549-023-07042-7. Epub 2023 Oct 25. Breast Cancer Res Treat. 2024. PMID: 37878150 Free PMC article.
-
Impact of procedure type on revisional surgery and secondary reconstruction after immediate breast reconstruction in a population-based cohort.Br J Surg. 2023 May 16;110(6):666-675. doi: 10.1093/bjs/znad050. Br J Surg. 2023. PMID: 36998148 Free PMC article.
-
Identifying research priorities for pituitary adenoma surgery: an international Delphi consensus statement.Pituitary. 2025 Mar 5;28(2):36. doi: 10.1007/s11102-025-01502-7. Pituitary. 2025. PMID: 40042764 Free PMC article.
-
Current axillary management of patients with early breast cancer and low-volume nodal disease undergoing primary surgery: results of a United Kingdom national practice survey.Breast Cancer Res Treat. 2024 Aug;206(3):465-471. doi: 10.1007/s10549-024-07328-4. Epub 2024 May 10. Breast Cancer Res Treat. 2024. PMID: 38724821 Free PMC article.
References
-
- Cancer Research UK. https://www.cancerresearchuk.org/health-professional/cancer-statistics/s... 2019 [Available from: https://www.cancerresearchuk.org/health-professional/cancer-statistics/s....
-
- Cancer IAfRo. Cancer today: Estimated number of new cases in 2020, worldwide, both sexes, all ages (excl. NMSC) 2022 [Available from: https://gco.iarc.fr/today/online-analysis-table?v=2020&mode=cancer&mode_....
-
- Allemani C, Weir HK, Carreira H, Harewood R, Spika D, Wang XS, et al. Global surveillance of cancer survival 1995–2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2) Lancet. 2015;385(9972):977–1010. doi: 10.1016/S0140-6736(14)62038-9. - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical